ABBV$294.891.41%4.10
After Hours: 295.30+0.41 +0.14%
Abbvie Inc (ABBV)
Date: 2026-10-30 16:00O: 292.00H: 298.74L: 291.01C: 294.89Vol: 6.896M
Abbvie Inc stock is traded at $294.89, with a volume of 6,896,435. It is up +1.41% in the last 24 hours and up +12.73% over the past month. AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
Previous Close:
$290.79
Open:
$292.00
24h Volume:
6,896,435
Relative Volume:
1.48
Market Cap:
$521.11B
Revenue:
$62.82B
Net Income/Loss:
$3.60B
P/E Ratio:
145.45
EPS:
$2.03
Net Cash Flow:
$19.98B
1W Performance:
+3.24%
1M Performance:
+12.73%
6M Performance:
+39.55%
1Y Performance:
+29.22%
1-Day Range:
$291.01$298.74
1-Week Range:
$281.23$298.74
52-Week Range:
$190.75$298.74
Abbvie Inc Stock (ABBV) Company Profile
Name
Abbvie IncSector
HealthcareIndustry
Drug Manufacturers - GeneralPhone
(847) 932-7900Address
1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL, USACompare ABBV vs LLY, JNJ, MRK, NVS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ABBV Abbvie Inc | $294.89 | $521.11B | $62.82B | $3.60B | $19.98B | $2.03 |
 LLY Lilly Eli Co | $1,417.54 | $1.26T | $72.25B | $25.28B | $10.37B | $27.78 |
 JNJ Johnson Johnson | $273.20 | $657.68B | $97.93B | $21.04B | $17.80B | $8.63 |
 MRK Merck Co Inc | $149.52 | $368.89B | $65.51B | $8.93B | $14.12B | $3.55 |
 NVS Novartis Ag Adr | $160.79 | $303.67B | $54.66B | $13.58B | $16.05B | $7.02 |
Abbvie Inc Stock (ABBV) Upgrades & Downgrades
Abbvie Inc Stock (ABBV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Abbvie Inc Stock (ABBV) Insider Trading
- Donoghoe NicholasAug 14 '26EVP, CHIEF BUS/STRAT OFFICER
- Transaction
- Sale
- Cost
- $250.00
- #Shares
- 32,710
- Value ($)
- 8,177,500
- #Shares Total
- 74,430
- NICHOLAS DONOGHOEAug 14 '26Officer
- Transaction
- Proposed Sale
- Cost
- $250.00
- #Shares
- 32,710
- Value ($)
- 8,177,500
- #Shares Total
- 0
- ROBERT J ALPERNMay 26 '26Director
- Transaction
- Proposed Sale
- Cost
- $214.00
- #Shares
- 13,000
- Value ($)
- 2,781,991
- #Shares Total
- 0
- Purdue David RyanMar 04 '26SVP, Controller
- Transaction
- Sale
- Cost
- $233.56
- #Shares
- 5,230
- Value ($)
- 1,221,519
- #Shares Total
- 2,654
- David R. PurdueMar 04 '26Officer
- Transaction
- Proposed Sale
- Cost
- $233.56
- #Shares
- 5,230
- Value ($)
- 1,221,519
- #Shares Total
- 0
- Siatis Perry CMar 02 '26EVP, GC AND SECRETARY
- Transaction
- Sale
- Cost
- $234.39
- #Shares
- 18,668
- Value ($)
- 4,375,549
- #Shares Total
- 4,619
- PERRY C SIATISMar 02 '26Officer
- Transaction
- Proposed Sale
- Cost
- $234.39
- #Shares
- 18,668
- Value ($)
- 4,375,585
- #Shares Total
- 0
- Siatis Perry CFeb 25 '26EVP, GC AND SECRETARY
- Transaction
- Option Exercise
- Cost
- $172.62
- #Shares
- 22,381
- Value ($)
- 3,863,458
- #Shares Total
- 60,518
- Siatis Perry CFeb 25 '26EVP, GC AND SECRETARY
- Transaction
- Sale
- Cost
- $230.00
- #Shares
- 22,381
- Value ($)
- 5,147,630
- #Shares Total
- 38,137
- PERRY C SIATISFeb 25 '26Officer
- Transaction
- Proposed Sale
- Cost
- $230.00
- #Shares
- 22,381
- Value ($)
- 5,147,630
- #Shares Total
- 0
